Endosomal Trafficking Defects Can Induce Calcium-Dependent Azole Tolerance in Candida albicans.
crossmark
Endosomal Trafficking Defects Can Induce Calcium-Dependent Azole
Tolerance in Candida albicans
Arturo Luna-Tapia, Hélène Tournu, Tracy L. Peters, Glen E. Palmer
Department of Clinical Pharmacy, Division of Clinical and Experimental Therapeutics, College of Pharmacy, University of Tennessee Health Sciences Center, Memphis,
Tennessee, USA
The azole antifungals arrest fungal growth through inhibition of ergosterol biosynthesis. We recently reported that a Candida
albicans vps21⌬/⌬ mutant, deficient in membrane trafficking through the late endosome/prevacuolar compartment (PVC), continues to grow in the presence of the azoles despite the depletion of cellular ergosterol. Here, we report that the vps21⌬/⌬ mutant
exhibits less plasma membrane damage upon azole treatment than the wild type, as measured by the release of a cytoplasmic
luciferase reporter into the culture supernatant. Our results also reveal that the vps21⌬/⌬ mutant has abnormal levels of intracellular Ca2ⴙ and, in the presence of fluconazole, enhanced expression of a calcineurin-responsive RTA2-GFP reporter. Furthermore, the azole tolerance phenotype of the vps21⌬/⌬ mutant is dependent upon both extracellular calcium levels and calcineurin activity. These findings underscore the importance of endosomal trafficking in determining the cellular consequences of
azole treatment and indicate that this may occur through modulation of calcium- and calcineurin-dependent responses.
S
everal important antifungal drugs inhibit the synthesis of
ergosterol, a lipid that modulates the thickness, fluidity,
and permeability of fungal cell membranes (1). These drugs
include the azoles, which inhibit lanosterol demethylase
(Erg11p). Both the depletion of cellular ergosterol and the accumulation of intermediate sterol species are thought to cause
plasma membrane dysfunction and, ultimately, growth arrest
following azole treatment (2). The emergence of azole-resistant
fungal isolates is a problem of increasing medical significance
(3). Several specific mechanisms that contribute to the development of azole resistance in the prevalent human fungal
pathogen Candida albicans have been described. These mechanisms include increased expression of the target enzyme, point
mutations that alter the target enzyme’s affinity for the azoles
(4, 5), and increased expression of efflux pumps, such as Cdr1p
and Mdr1p, that export the azoles out of the fungal cell (6–8).
However, the azole resistance of many fungal isolates is not
fully accounted for by these well-characterized mechanisms.
We recently reported that membrane trafficking through the
late endosome/prevacuolar compartment (PVC) has a significant impact upon C. albicans azole tolerance (9). Specifically,
we found that a deletion of VPS21, which encodes a Rab
GTPase required for PVC trafficking, substantially enhanced C.
albicans growth in the presence of the azoles. The azole tolerance of the vps21⌬/⌬ mutant does not depend upon established
mechanisms of azole resistance such as the activity of the wellcharacterized drug efflux pumps Mdr1p and Cdr1p, or increased target protein expression, but occurs despite the depletion of cellular ergosterol (9). This phenotype resembles an
exaggerated form of “trailing growth,” a phenomenon that is
observed using standard CLSI antifungal susceptibility testing
protocols (10), in which a subset of C. albicans isolates appear to
be azole susceptible at early time points but display significant
growth at later time points (10). The objective of this study was
to define the mechanism(s) underlying the azole tolerance of
the C. albicans vps21⌬/⌬ mutant.
7170
aac.asm.org
MATERIALS AND METHODS
Growth conditions. C. albicans was routinely grown at 30°C in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) supplemented with
uridine (50 g/ml) when necessary. Transformant selection was carried
out on minimal YNB medium (6.75 g/liter yeast nitrogen base without
amino acids, 2% dextrose, 2% Bacto agar) supplemented with the appropriate auxotrophic requirements, as described previously for Saccharomyces cerevisiae (11), or 50 g/ml uridine.
Plasmid construction. Plasmid pLUX (12) was kindly provided by
William Fonzi (Georgetown University). Plasmids pLUXVPS21 (13),
pKE1 (14), and pKE1-NLUC (15) were described previously. All oligonucleotides used in this study are listed in Table S1 in the supplemental material. The VPH1 open reading frame (ORF) with 5=- and
3=-untranslated region (UTR) sequences was amplified from SC5314
genomic DNA (gDNA) with HiFi Platinum Taq (Invitrogen) and
primer set VPH1AMPF and VPH1AMPR-KpnI and cloned between the
SacI and KpnI restriction sites of pLUX to produce plasmid pLUXVPH1.
For the construction of reporter plasmid pRTA2prGFP␥, 1,000 bp of
the RTA2 promoter was amplified from SC5314 gDNA with primer pair
RTA2prF-KpnI and RTA2prR-SalI and cloned between the KpnI and SalI
sites of pKE1 in place of the ACT1 promoter. The GFP␥ (green fluorescent protein) coding sequence was then amplified by using primers
GFPAMPF-SalI and GFPAMPR-MluI and cloned downstream of the
RTA2 promoter between the SalI and MluI sites.
C. albicans strains. All strains used in this study are listed in Table S2
in the supplemental material. The vps21⌬/⌬, aps3⌬/⌬, and vps21⌬/⌬
Received 13 May 2016 Returned for modification 22 June 2016
Accepted 11 September 2016
Accepted manuscript posted online 19 September 2016
Citation Luna-Tapia A, Tournu H, Peters TL, Palmer GE. 2016. Endosomal
trafficking defects can induce calcium-dependent azole tolerance in Candida
albicans. Antimicrob Agents Chemother 60:7170 –7177.
doi:10.1128/AAC.01034-16.
Address correspondence to Glen E. Palmer, .
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/AAC.01034-16.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Antimicrobial Agents and Chemotherapy
December 2016 Volume 60 Number 12
Azole Tolerance of C. albicans vps21Δ/Δ Mutant
aps3⌬/⌬ mutants were constructed in previous studies (13, 14, 16, 17).
Control strain YJB6284 (18) was kindly provided by Judith Berman (Tel
Aviv University). Transformation of C. albicans with DNA constructs was
performed by using the lithium acetate method (19). Gene deletion
strains were constructed by a PCR-based approach described previously
by Wilson et al. (20), using ura3⌬/⌬ his1⌬/⌬ arg4⌬/⌬ strain BWP17
(kindly provided by Aaron Mitchell, Carnegie Mellon University). Strain
CAI4 was kindly provided by William Fonzi (Georgetown University).
VPH1 deletion cassettes were amplified by PCR with primers
VPH1DISF and VPH1DISR, using pRS-ARG4⌬SpeI, pGEM-HIS1, or
pDDB57 (containing a recyclable URA3-dpl200 marker) (20, 21) as the
template. Each VPH1 allele was sequentially deleted by using HIS1 and
ARG4 markers to generate vph1⌬/⌬ ura3⌬/⌬ gene deletion mutants. The
correct integration of the deletion cassettes was confirmed at each step by
PCR with the following primers sets: AR (...truncated)